Author

Cornelius Maximilian Funk

German Cancer Research CenterORCID 0000-0002-0837-3237Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Katharina CeranskiiD· 1 shared Alina DahlhausiD· 1 shared Alina S. Ritter· 1 shared Ana BanitoiD· 1 shared Anna C. EhlersiD· 1 shared Christina MertensiD· 1 shared David Obermeier· 1 shared Endrit VincaiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Katharina CeranskiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Glutaredoxin 3 (GLRX3) confers a fusion oncogene-dependent vulnerability to Ewing sarcoma

Endrit Vinca, Anna C. Ehlers, Alina S. Ritter, David Obermeier, Cornelius Maximilian Funk, Florian H. Geyer, Melissa Schmucker, Jing Li, Malenka Zimmermann, A. Katharina Ceranski, Fabia Fuchslocher, Christina Mertens, Ruiyue Qiu, Martina Ulrike Muckenthaler, Alina Dahlhaus, , Shunya Ohmura

This study identifies GLRX3 as a vulnerability in Ewing sarcoma driven by EWSR1::FLI1 fusion oncoproteins, showing its role in oxidative stress and iron homeostasis and potential therapeutic targeting.

bioRxiv · Apr 24, 2024 · PreprintCancer Biology